Individuals Discontinuing Weight-Loss Injections Gain Back Pounds at a Quadrupled Rate Compared to Those on Conventional Diets

Fresh analysis indicates that people who stop using popular GLP-1 drugs like Wegovy and Mounjaro tend to recover reduced body mass much more quickly than those who stop traditional lifestyle regimens.

Findings released in a prominent health publication shows that while obese individuals can lose a large proportion of their body weight while undergoing treatment, the weight comes back at an average rate of 0.8 kg per month after stopping.

"Individuals buying these medications should be aware of the risk of quick weight regain when the therapy is stopped," stated expert Dr. Susan Jebb.

This pace of regain means a reversion to original weight in about one and a half years.

Comparing Approaches

The research, which reviewed dozens of trials involving thousands of patients, contrasted the outcomes of the injectable medications with conventional dieting.

The team point out that people who shed pounds through lifestyle changes alone generally see a more gradual weight regain—around 0.1 kg a month—once they finish.

The Reason for the Quick Regain

Doctors propose the mode of action of the injections explains the heightened rebound.

GLP-1 drugs mimic a natural hormone called GLP-1, which moderates hunger.

"Artificially providing GLP-1 levels far above than the body's typical production might result in the system to generate a reduced amount of its endogenous hormone, and may also reduce sensitivity to its effects," noted Dr. Adam Collins, a dietetics expert.

"Withdrawal of this medication means hunger is unsuppressed, making binge eating much more probable."

An Ongoing Disease?

The NHS advise the injections for people with weight-linked health risks, accompanied by recommended diet and exercise modifications.

A number of clinicians say that, due to the significant potential of weight regain, the therapy is often life-long.

This view is echoed by drug manufacturers, who note that the findings "highlight the chronic character of excess weight," comparing it to managing conditions like hypertension.

Patient Experiences

People who have stopped the jabs report a sudden return of hunger.

"I experienced something activating and you become extremely hungry," said a patient.

This difficulty is worsened if users have not developed sustainable lifestyle or habit changes during treatment.

Widespread Interest

Recent estimates suggest that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with demand being substantial.

• Adoption is greater among females compared to men.
• The 40s and 50s demographic shows the highest level of interest.
• Many access the medications through private healthcare rather than public health services.

In conclusion, clinicians caution that while GLP-1 drugs are effective tools for shedding pounds, they are not a magic solution and lasting health benefits relies on integrated lifestyle changes.